COMPANY PROFILE

OpenTrons

Explore full profile

OpenTrons is open-source rapid prototyping for biology

New York City, United StatesFounded 2013Biotech & Life Sciences

Valuation $1–2.5B Last recorded · 2021

Headcount 100–500 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About OpenTrons

Opentrons is a startup that specializes in providing affordable and user-friendly laboratory automation solutions. The company operates primarily in the biotechnology and life sciences market, serving a diverse range of clients including academic research institutions, pharmaceutical companies, and clinical laboratories. Opentrons' main product is the OT-2, a versatile and cost-effective liquid handling robot designed to automate repetitive lab tasks such as pipetting, which is the process of transferring liquids between containers.

Read full description

The business model of Opentrons revolves around selling these robotic systems along with complementary software and consumables. The company generates revenue through the direct sale of its hardware products, as well as through subscriptions and one-time purchases of its software solutions. Additionally, Opentrons offers a range of consumables and accessories that are essential for the operation of their robots, providing another stream of recurring revenue.

Opentrons stands out in the market by making laboratory automation accessible to smaller labs and institutions that may not have the budget for traditional, more expensive automation solutions. Their products are designed to be easy to set up and use, reducing the barrier to entry for labs looking to adopt automation technology. This focus on affordability and ease of use has allowed Opentrons to carve out a niche in a market that has traditionally been dominated by high-cost, complex systems.

In summary, Opentrons is transforming the landscape of laboratory automation by offering cost-effective, user-friendly robotic solutions that cater to a wide range of clients in the biotechnology and life sciences sectors. The company's innovative approach and commitment to accessibility have positioned it as a key player in the market.

Source: Dealroom company data